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Objective. The aim of this investigation was to examine the bone regenerative potential of newly biphasic calcium phosphate
ceramics (HA-𝛽-TCP 30/70), by assessing histological and histomorphometric results of human specimens retrieved from sinuses
augmented with HA-𝛽-TCP 30/70, and comparing them to anorganic bovine bone (ABB), mineralized solvent-dehydrated bone
allograft (MSDBA), and equine bone (EB), after a healing period of 6months.Materials andMethods. Four consecutive patientswith
edentulous atrophic posterior maxilla were included in this report. A two-stage procedure was carried out for sinus augmentation
with HA-𝛽-TCP 30/70, ABB, MSDBA, and EB. After 6 months, specimens were retrieved at the time of implant placement and
processed for histological and histomorphometric analyses. Results. At histological examination, all biomaterials were in close
contact with the newly formed bone and showed the same pattern of bone formation; the grafted granules were surrounded by
a bridge-like network of newly formed bone. A limited number of ABB particles were partially covered by connective tissue. The
histomorphometric analysis revealed 30.2% newly formed bone for Ha-𝛽-TCP 30/70, 20.1% for ABB, 16.4% for MSDBA, and 21.9%
for EB. Conclusions. Within the limitations of the present investigation, these results support the successful use of HA-𝛽-TCP 30/70
for sinus augmentation.
1. Introduction
Deficiencies in the volume and quality of available bone can
complicate implant placement in the resorbed maxillary jaw.
Sinus grafting in the maxillary posterior region is a highly
predictable procedure to increase the vertical volume of sinus
floor bone to accommodate dental implants [1, 2].
Autologous bone is considered the gold standard for bone
regeneration [3, 4], even if different bone substitutes have
been proposed to overcome the limits related to its use,
specifically, donor site morbidity, increased operating time,
need of a second surgical site to obtain the transplant, and
potential intraoperative and postoperative complications [5–
7]. After implant placement, a resorption with up to 49.5%
marked volume loss has been reported in the literature after 6
months from sinus grafting [8, 9]. A number of graftmaterials
with different origin and mechanism of bone regeneration
have been used alone or in combination with autografts
in sinus floor augmentations [10–20]. Therefore the current
issue is the definition of the best filling material for the sinus
cavity. The presence or absence of autogenous bone in a graft
did not affect implant survival [21, 22] and different studies
have suggested that some alternative augmentation materials
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may not adversely influence clinical outcomes and implant
survival [23, 24].
Among the graft materials used in maxillary sinus aug-
mentation procedures, biphasic calcium phosphate ceramics,
reached bymixing hydroxyapatite (HA) and tricalcium phos-
phate (TCP), are considered biocompatible, osteoconductive,
and suitable to obtain bone formation [24]-[25]. The HA,
undergoing slow resorption, works as a scaffold to maintain
space, while the TCP that underwent quick dissolution
leads to more interparticle space and releases calcium and
phosphorus ions that could stimulate new bone formation,
promoting osteogenic activity [26]. Currently several bioce-
ramic materials are used and differences in HA/TCP ratio,
phase composition, formulation, sizes, and shapes affect their
biological and mechanical properties [10, 18], [24], [27–29].
The newly biphasic calcium phosphate ceramics (HA-𝛽-
TCP 30/70) with reticular structure, tested in the present
investigation, seem to have a better resorption and an
increased bone formation [18].
Anorganic bovine bone (ABB) is a deproteinized ster-
ilized bovine bone, constituted by a calcium-deficient car-
bonate apatite, with 75% porosity and a crystal size of about
10 nm in the form of granules. Due to its natural structure,
it is chemically and physically comparable to human bone
and its porous nature, greatly increasing the surface area
of the material, promotes angiogenesis and immigration of
osteogenic cells [19].The usage of ABB is widely documented
and shows that it can well integrate in host bone tissue in
different clinical and histological results [30–32].
MSDBA is a solvent-dehydrated, limited-dose, gamma-
irradiated portions of human iliac crest bone wedge. The
allograft mixture contains 50% cortical and 50% cancellous
microchips with a particle size of 1-2mm. MSDBA showed
significant histological results in terms of newbone formation
after sinus augmentation procedures [10, 11, 33].
Equine-derived bone (EB) is an equine-derived bone
tissue deantigenated by a proteolytic low-temperature pro-
cess that eliminates the organic components but leaves the
mineral structure of the hydroxyapatite unaltered, saving
the resorption potential [12]. Recent investigations showed
that also the equine-derived bone (EB) is able to induce
bone formation in maxillary sinus augmentations [12, 13, 34,
35].
Although the number of newly formed bones in the
augmented sinus is not directly related to the survival rate of
the implants, histological and histomorphometric analysis of
specimens, retrieved at the time of implant placement (after
a healing period of 6 months), represents a reliable indicator
to assess and compare the performance of the graft materials
[19].
The aim of this investigation was to examine the bone
regenerative potential of a newly biphasic calcium phosphate
ceramics (HA-𝛽-TCP 30/70), by assessing histological and
histomorphometric results of human specimens retrieved
from sinuses augmented with HA-𝛽-TCP 30/70, and com-
paring them to anorganic bovine bone (ABB), mineralized
solvent-dehydrated bone allograft (MSDBA), and equine
bone (EB), after a healing period of 6 months.
2. Materials and Methods
2.1. Patient Selection. Four healthy patients (3 males, 1
females, all nonsmokers, mean age 52 years, range 36–70
years), scheduled for sinus augmentation in the atrophic
posterior maxilla to receive fixed restorations, were recruited
for this study. Inclusion criteria were maxillary partial eden-
tulism in the premolar/molar areas and subsinus residual
bone height, measured on computerized tomography (CT)
scan, ranging from 2 to 4mm and bone thickness 3–5mm.
Exclusion criteria were smoking, patients with systemic
diseases and maxillary sinus pathology. The clinical proce-
dures were performed in accordance with the Declaration
of Helsinki and the Good Clinical Practice Guidelines. All
patients signed a written informed consent form. After
reviewing medical history and making a preliminary clinical
examination, digital panoramic radiography and CT scan
were performed. A two-stage procedure was carried out
for sinus floor augmentation with HA-𝛽-TCP 30/70, ABB,
MCBA, and EB. These materials were allocated to the par-
ticipant’s sinus under randomized conditions. After a healing
period of 6 months, specimens were retrieved at the time
of implant placement and processed for histological and
histomorphometric analyses.
2.2. Surgical Procedure. Surgery was performed under sterile
conditions and local anaesthesia with mepivacaine 2% with
epinephrine 1 : 100.000 (Carbocaine, AstraZeneca, Italy). On
the day of surgery, each patient was administered 2 g
amoxicillin + clavulanic acid (Augmentin, GlaxoSmithKline,
London, UK) 1 hour prior to surgery and rinsed with a
chlorhexidine digluconate solution 0.2% (Corsodyl, Glaxo-
SmithKline, Belgium) for 2min immediately prior to the
intervention. Sinus floor elevation was performed utilizing a
lateral window technique. A slightly palatal crestal incision
was made and supplemented by buccal releasing incisions
mesially and distally. Full thickness flaps were elevated to
expose the alveolar crest and the lateral sinus wall. An
oval-shaped osteotomy, with the inferior border about 5mm
superior to the alveolar bone margin, was made on the
lateral aspect of the sinus wall using a round bur under cold
sterile saline irrigation. The center of the bony window was
gently in-fractured with care to ensure that its most superior
portion was left intact. The sinus membrane was carefully
elevated and rotated, together with the osteotomy window,
inward and upward.The exposed sinus cavity was augmented
with HA-𝛽-TCP 30/70 ABB, MCBA, or EB. The graft was
placed and carefully packed into the area between the elevated
Schneiderian membrane and sinus floor without excessive
pressure. A resorbable membrane was placed over the lateral
wall of the sinus and the mucoperiosteal flap was replaced
and stabilized with monofilament, nonresorbable, expanded
polytetrafluoroethylene (e-PTFE) (Gore-Tex Suture, W. L.
Gore, Flagstaff, AZ, USA) sutures. No Schneiderian mem-
branes were perforated during any of the sinus augmentation
procedures. For the postoperative phase, the patients were
protected from infection by administration of prophylactic
antibiotics (Augmentin, GlaxoSmithKline, London, UK) 1 g,
2 times daily for 1 week; an analgesic and antiphlogistic
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medication (Ibifen, 200mg -IBI-Lorenzini, Aprilia, Italy)
was prescribed 3 times daily. The patient was instructed
to avoid use of a removable prosthesis, not to blow the
nose, and to rinse twice daily for a period of 2 weeks with
0.2% chlorhexidine gluconate. Following a healing period
of 2 weeks, sutures were removed. Six months after the
augmentation procedure, clinical and radiographic exami-
nation were undertaken and each patient was reappointed
for biopsy at the time of implant placement in the same
location. Under local anesthesia, a vertical incision was made
buccally and continued horizontally and distally at the palatal
side of the alveolar crest. A full thickness flap was raised
and mobilized for tension-free closure. During this surgery,
a total of 4 bone samples were retrieved with a 3.5 trephine
bur under sterile saline solution irrigation, one from each
augmented site. From 1 to 6 implants were placed into each
patient’s augmented sinus according to the manufacturer’s
directions.
2.3. Histological Procedure. The bone cores were retrieved
and were immediately stored in 10% buffered formalin and
processed to obtain thin ground sections.The specimenswere
processed using the Precise 1 Automated System (Assing,
Rome, Italy) [36].The specimenswere dehydrated in a graded
series of ethanol rinses and embedded in a glycolmethacrylate
resin (Technovit 7200 VLC, Kulzer, Wehrheim, Germany).
After polymerization, the specimens were sectioned, along
their longitudinal axis, with a high precision diamond disk
at about 150 𝜇m and ground down to about 30 𝜇m with a
specially designed grinding machine Precise 1 Automated
System (Assing, Rome, Italy). Three slides were obtained
from each specimen. These slides were stained with acid
fuchsin and toluidine blue and examined with transmitted
light Leitz Laborlux microscope (Leitz, Wetzlar, Germany).
Histomorphometry of the percentages of newly formed bone,
residual grafted material, and marrow spaces was carried
out using a light microscope (Laborlux S, Leitz, Wetzlar,
Germany) connected to a high-resolution video camera
(3CCD, JVCKY-F55B, JVC, Yokohama, Japan) and interfaced
with a monitor and PC (Intel Pentium III 1200 MMX, Intel,
Santa Clara, CA, USA). This optical system was associated
with a digitizing pad (Matrix Vision GmbH, Oppenweiler,
Germany) and a histometry software packagewith image cap-
turing capabilities (Image-Pro Plus 4.5, Media Cybernetics
Inc., Immagini & Computer Snc, Milano, Italy).
3. Results
3.1. Clinical Results. In all cases, no perforations of the
Schneiderian membrane were present, primary stability of
the implants was achieved, regardless of the bone graft
substitute used, and postoperative complicationswere absent.
The healing process after sinus augmentation procedure was
uneventful and no clinical signs of sinus pathology were
observed. Six months after augmentation, the radiographic
examination showed in all patients the presence of dense
bone in the maxillary sinuses where the biomaterials were
inserted.
NB
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Figure 1: Grafted HA-𝛽-TCP 30/70 (HA) particles, almost com-
pletely surrounded by newly formed bone (NB) (acid fuchsin-
toluidine blue; original magnification 12x).
NB
HA
MS
Figure 2: Marrow stromal cells (MS) and blood vessels were found
in the vicinity of newly formed bone (NB) surrounding HA-𝛽-
TCP 30/70 particles (HA) (acid fuchsin-toluidine blue; original
magnification 100x).
3.2. Histological and Histomorphometric Results
3.2.1. Biphasic Calcium Phosphate Ceramics (HA-𝛽-TCP
30/70). At low magnification, a large number of grafted
biomaterials, completely surrounded by newly formed bone,
were observed (Figure 1). In some fields osteoblasts were
detected in the process of apposing bone directly on the
particle surface. No gaps were present at the bone-particles
interface, and the bone was always in close contact with
the particles. Marrow stromal cells and blood vessels were
found inside the marrow spaces. A vascular growth was
also observed next to the newly formed bone (Figure 2).
No inflammatory cells or foreign body reaction was noted
around the grafted particles. Histomorphometry showed that
newly formed bone represented 30.2%,marrow spaces 40.7%,
and the residual graft material 29.1%.
3.2.2. Anorganic Bovine Bone (ABB). At low magnification,
trabecular bone with large marrow spaces was observed
(Figure 3). Some of the particles appeared to be cemented
by this newly formed bone. At higher magnification, the
bone presented wide osteocyte lacunae (Figure 4). A limited
number of anorganic bovine bone particles were partially
covered by connective tissue. No inflammatory cell infiltrate
was present around the particles or at the interface with
bone. Histomorphometry showed that newly formed bone
represented 20.1%, marrow spaces 60.8%, and the residual
graft material 19.1%.
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Figure 3: Trabecular bone (B) with large marrow spaces and resid-
ual ABB (ABB) particles can be observed (acid fuchsin-toluidine
blue; original magnification 30x).
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Figure 4: Newly formed trabecular bone (NB) is in close contact
with ABB (ABB) particle, with no gaps at the bone-particle interface
(acid fuchsin-toluidine blue; original magnification 400x).
3.2.3. Mineralized Solvent-Dehydrated Bone Allograft
(MSDBA). At low magnification, trabecular bone with
large marrow spaces was observed (Figure 5). Few particles
presented irregularly shaped margins, probably due to a
resorption process. There were no gaps at the bone-particle
interface and the new bone was in strict contact with
the granules. In some fields, osteoblasts were observed
in the process of apposing bone directly on the particle
surface (Figure 6). Newly formed bone was characterized
by large osteocyte lacunae and bridged up most part of the
biomaterial particles. Histomorphometry showed that newly
formed bone represented 16.4%, marrow spaces 65.1%, and
the residual graft material 18.5%.
3.2.4. Equine Bone (EB). At low magnification, trabecular
bone with large marrow spaces was observed. In a portion
of the specimen, preexisting bone with areas of remodeling
was present (Figure 7). Some of the particles appeared to
be cemented by the newly formed bone. At higher magnifi-
cation, the bone showed wide osteocyte lacunae (Figure 8).
Some trabeculae of the grafted material were bridged by
newly formed bone. No inflammatory cells or multinucleated
cells were observed around the particles or at newly formed
bone-biomaterial interface in the marrow spaces. Histomor-
phometry showed that newly formed bone represented 21.9%,
marrow spaces 54.9%, and the residual graft material 23.2%.
MS
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Figure 5: Trabecular bone (B) with large marrow spaces (MS)
and residual MSDBA (G) particles can be observed (acid fuchsin-
toluidine blue; original magnification 10x).
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Figure 6: In some fields, osteoblasts (Os) were observed in the
process of apposing bone directly on the MSDBA (G) particles’
surface (acid fuchsin-toluidine blue; original magnification 200x).
4. Discussion
In sinus augmentation procedures, the choice of bone substi-
tutes plays a key role, because their different properties affect
medium and long-term success of implant rehabilitation.
However, clinical and histological outcomes about bone
substitute materials and management and timing of implant
placement and their follow-up still remain open questions,
because there are no clear guidelines for the use of autogenous
bone or bone substitutes [24]. Numerous studies have com-
pared grafting materials after sinus augmentation, reporting
small numbers of histology samples as our investigation
[11, 19, 21, 22, 26, 27, 30]. Therefore, it is very important to
histologically evaluate the healing process of bone substitute
materials, after two-stage sinus augmentation, in order to
increase the knowledge about their biological behavior in
humans [37].
In the present preliminary investigation, to examine the
bone regenerative potential of a newly biphasic calcium
phosphate ceramic, the histologic process of healing and
bone formation of HA-𝛽-TCP (30/70) was compared to
those of the most frequently used and well documented
biomaterials after six months from sinus augmentation [10–
13, 17–20]. The present scaffold was developed by the direct
rapid prototyping technique dispense-plotting, as previously
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Figure 7: Trabecular bone (B) with large marrow spaces (MS) and
residual EB (EB) particles were present (acid fuchsin-toluidine blue;
original magnification 12x).
NB
EB
Figure 8: Newly formed bone (NB) with wide osteocyte lacunae
(black arrow) in tight contact with EB (EB) particles (acid fuchsin-
toluidine blue; original magnification 200x).
described by Deisinger et al. [38] and Mangano et al. [18].
This method enables tuning the HA/𝛽-TCP ratio, surface,
structure, and micro- and macroporosity which in turn
influence the regenerative potential. Indeed, the pattern of
resorption and the healing process would be influenced by
the variation of the ratio between the component at slow
resorption (HA) and those at more fast resorption (𝛽-TCP),
even if no statistical significant difference was found by
Schopper et al. [39], comparing two different ratios (30/70
versus 50/50) of HA/TCP in a sheep model, although a better
integration into the host bone was observed in the 30/70
composition. On the contrary in a comparative study of
biphasic calcium phosphates with different HA/TCP ratios
in mandibular bone defects of minipig, the BCP (20/80),
unlike BCP (60/40) and BCP (80/20), showed results similar
to those of autogenous bone grafts, indicating that the ratio of
HA/TCP (60/40) might not be optimal for bone healing [40].
The three-dimensional networkwith an interconnecting pore
structure promotes the vascularization that is essential for the
proliferation and differentiation of osteoblasts and therefore
for the ingrowth of new bone into the graft [41].
At the histologic examination, the HA-𝛽-TCP (30/70)
scaffold showed a pattern of bone formation similar to the
other biomaterials tested, with a large number of grafts,
completely surrounded by newly formed bone, that was
always in close contact, without gaps, with the particles.
Furthermore, osteoblasts, in some fields, were detected in the
apposing bone directly on the particle surface, the marrow
stromal cells and blood vessels were found inside the marrow
spaces and the vascular growth was observed next to the
newly formed bone. These histological data, in agreement
with those reported in a similar study about evaluation
of HA-𝛽-TCP (40/60) in sinus elevation after a healing
period of 6 months [42], demonstrated that the HA-𝛽-TCP
is an osteoconductive and resorbable material. The absence
of inflammatory cells or foreign body reaction around the
grafted particles testifies safety and biocompatibility.
For the ABB sample a limited number of grafted particles
were found partially covered by connective tissue while some
of the particles appeared to be cemented by this newly formed
bone. The ABB sample was smaller than the others and
this was due to the fracture of the bone biopsy retrieved
from the ABB augmented site during the removal from the
trephine bur. ABB is a nonresorbable bone substitute and
has osteoconductive properties. Its structure could represent
a type of protection against bone resorption, guaranteeing
long-term stability of the augmentedmaxillary sinus [10].The
MSDBA sample confirmed the biocompatibility, ease of use,
and ability to form and maintain new bone in the maxillary
sinus as reported by previous studies [11, 26]. No signs of
acute inflammationwere present, and the percentage of newly
formed bone and residual graft material were comparable to
those reported for other biomaterials [43]. The EB sample
showed some trabeculae bridged by newly formed bone. Our
results are comparable to other investigations [12, 13]. It is
evident resorption phenomena, and its ability to achieve a
more rapid and intense vascularization is very important
also in influencing long-term integration and predictability
of implant-prosthetic rehabilitation in regenerated sites. Its
higher resorption ability could probably be due to a deanti-
genation process this grafting material undergoes [13]. The
results of the present investigation revealed that HA-𝛽-TCP
(30/70) could provide a better result in sinus augmentation
procedures compared to the other biomaterials. No histo-
logical signs of adverse reactions were observed. Results
from this preliminary investigation have shown that HA-𝛽-
TCP (30/70) has good biocompatibility, with no histological
signs of adverse reactions, and osteoconductivity, with bone
formation directly on the biomaterial surface. Nevertheless
the presence of a high quantity of the biomaterial particles
after 6 months will require long-term histological studies
to better understand the times and the modalities of the
resorption of this graft.
In conclusion, within the limitations of the present
report the histological and histomorphometric observations
support the fact that Ha-TCP (30/70) can be suitable for
successful augmentation procedures of the maxillary sinus
and represents a very interesting option.
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